Received: 2 July 2020
Accepted: 25 August 2020
First Online: 1 December 2020
Ethics approval and consent to participate
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
: Not applicable.
: The authors report no financial affiliation or other relationship relevant to the subject matter of this article. JS is a Visiting Professor at Diderot University, Paris and an Honorary Professor at Kings College, London. AY declares paid lectures and advisory boards for the following companies with drugs used in affective and related disorders: AstraZeneca, Eli Lilly, Lundbeck, Sunovion, Servier, Livanova, and Janssen. He is a paid consultant to Johnson & Johnson, is lead Investigator for Embolden Study (AstraZeneca), BCI Neuroplasticity study and a pharma sponsored Aripiprazole in Mania study. His institution has received funding for investigator-initiated studies from AstraZeneca, Eli Lilly, Linova, Lundbeck, Wyeth, and Janssen.